O'Neil Global Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-96,103
Closed -$8.39M 70
2025
Q2
$8.39M Buy
+96,103
New +$7.53M 1.93% 16
2023
Q3
Sell
-85,845
Closed -$11M 66
2023
Q2
$11M Buy
85,845
+83,423
+3,444% +$10.1M 2.29% 13
2023
Q1
$281K Sell
2,422
-2,650
-52% -$297K 0.14% 58
2022
Q4
$574K Buy
+5,072
New +$557K 2.65% 11
2021
Q4
Sell
-42,972
Closed -$5.88M 66
2021
Q3
$5.88M Buy
+42,972
New +$5.42M 4.51% 6

Other funds holding DXCM

O'Neil Global Advisors's DXCM Position: Q3 2025 in Review

O'Neil Global Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 96,103 shares — an estimated $8.39M sold.

O'Neil Global Advisors first reported a position in DXCM in Q3 2021 and held it in 5 quarters. The position peaked at $11M in Q2 2023. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • O'Neil Global Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • O'Neil Global Advisors sold 96,103 DexCom shares in Q3 2025, an estimated $8.39M.
  • O'Neil Global Advisors first reported a position in DexCom in Q3 2021 and held it in 5 quarters.
  • O'Neil Global Advisors's DexCom position peaked at $11M in Q2 2023.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on O'Neil Global Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.